![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 11
2020
Mittlmeier, Lena M.; Unterrainer, Marcus; Rodler, S.; Todica, A.; Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624; Burgard, C.; Cyran, C. C.; Kunz, W. G.; Ricke, J.; Bartenstein, P.; Stief, C. G.; Ilhan, H. und Staehler, Michael
(2020):
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.
In: European journal of nuclear medicine and molecular imaging
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0953-7624; Burgard, C.; Cyran, C. C.; Kunz, W. G.; Ricke, J.; Bartenstein, P.; Stief, C. G.; Ilhan, H. und Staehler, Michael
(2020):
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.
In: European journal of nuclear medicine and molecular imaging
[PDF, 2MB]
Ilhan, H.; la Fougere, C. und Krause, B. J.
(2020):
PSMA-basierte Theranostik beim Prostatakarzinom. Von der Bildgebung zur Therapie.
In: Urologe, Bd. 59, Nr. 5: S. 617-623
Unterrainer, M.; Eze, C.; Ilhan, H.; Marschner, S.; Roengvoraphoj, O.; Schmidt-Hegemann, N. S.; Walter, F.; Kunz, W. G.; Munck af Rosenschold, P.; Jeraj, R.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
2019
Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
A look ahead: future directions of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
A look ahead: future directions of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362
Rudisile, S.; Gosewisch, A.; Wenter, V; Unterrainer, M.; Boening, G.; Gildehaus, F. J.; Fendler, W. P.; Auernhammer, C. J.; Spitzweg, C.; Bartenstein, P.; Todica, A. und Ilhan, H.
(2019):
Salvage PRRT with Lu-177-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival.
In: BMC Cancer, Bd. 19, Nr. 1, 788
Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Current status of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Current status of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180
2017
Zollner, B. D.; Vettermann, F.; Ilhan, H.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Ganswindt, U.; Belka, C. und Niyazi, M.
(2017):
[68Ga]DOTATATE-PET-basierte Zielvolumendefinition bei Meningeomen WHO Grad I.
In: Strahlentherapie und Onkologie, Bd. 193:
S152-S152
ORCID: https://orcid.org/0000-0003-0953-7624; Ganswindt, U.; Belka, C. und Niyazi, M.
(2017):
[68Ga]DOTATATE-PET-basierte Zielvolumendefinition bei Meningeomen WHO Grad I.
In: Strahlentherapie und Onkologie, Bd. 193:
S152-S152
Paprottka, K. J.; Schoeppe, F.; Ingrisch, M.; Rübenthaler, J.; Sommer, N. N.; Toni, E. de; Ilhan, H.; Zacherl, M.; Todica, A. und Paprottka, P. M.
(2017):
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 7: S. 1185-1193
Jakobs, T. F.; Paprottka, K. J.; Raeßler, F.; Strobl, F.; Lehner, S.; Ilhan, H.; Trumm, C. G.; Fendler, W. P.; Sommer, W. und Paprottka, P. M.
(2017):
Robust evidence for long-term survival with Y-90 radioembolization in chemorefractory liver-predominant metastatic colorectal cancer.
In: European Radiology, Bd. 27, Nr. 1: S. 113-119
Walter, F.; Jell, C.; Ilhan, H.; Belka, C.; Niyazi, M.; Jensen, A. D. und Falk, R.
(2017):
Anwendbarkeit semiautomatischer PET-Konturierung anhand des biologischen Tumorvolumens zur Zielvolumendefinition beim Ösophaguskarzinom.
In: Strahlentherapie und Onkologie, Bd. 193:
S174-S175
2016
Delker, A.; Gosewisch, A.; Rieger, S.; Ilhan, H.; Fendler, W.; Gildehaus, F.; Bartenstein, P. und Boening, G.
(2016):
Dosimetry for Lu-177-PSMA therapy of patients with mCRPC: A comparison of 3D SPECT and 2D planar methods.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S213-S214